Mark‐David Levin
Mark‐David Levin publishes mostly in Genetics, Hematology and Oncology, on topics such as Chronic Lymphocytic Leukemia Research, Multiple Myeloma Research and Treatments and Lymphoma Diagnosis and Treatment.
- World rank
- #698,180 of 7,710,434 ranked researchers
- Rank in Netherlands
- #16,807 of 107,149
- Works
- 308
- Citations
- 6.8k
- Citations per work
- 22.0
What does Mark‐David Levin research?
Mark‐David Levin's work is mostly in Medicine (62%), Immunology and Microbiology (7%), Biochemistry, Genetics and Molecular Biology (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences19262.2%
- Medicine19262.2%
- Everything else7223.4%
- Life Sciences4414.4%
- 1Genetics20% of their works
- 2Hematology20% of their works
- 3Oncology12% of their works
- 4Pathology and Forensic Medicine10% of their works
- 5Immunology7% of their works
- 6Molecular Biology7% of their works
Research topics
Which keywords describe Mark‐David Levin's research?
The keywords of their largest research topics: Rituximab, Chronic Lymphocytic Leukemia, Genomic Aberrations, Diagnosis Criteria, International Myeloma Working Group, Classification, Lymphoma and Metastatic Breast Cancer.
- Imatinib
- CDK4/6 Inhibitors
- Primary Immunodeficiency
- Taxanes
- PROTACs
- Metastatic Breast Cancer
- Classification
- Diagnosis Criteria
- Chronic Lymphocytic Leukemia
- Rituximab
- Genomic Aberrations
- International Myeloma Working Group
- Lymphoma
- BET Bromodomains
- Chemotherapy-Induced Peripheral Neuropathy
- Genetic Mutations
- Breast Cancer
- BCR-ABL
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 18 words, with their numbers
- Rituximab2132 topics
- Chronic Lymphocytic Leukemia1391 topic
- Genomic Aberrations1391 topic
- Diagnosis Criteria791 topic
- International Myeloma Working Group791 topic
- Classification741 topic
- Lymphoma741 topic
- Metastatic Breast Cancer482 topics
- BET Bromodomains321 topic
- PROTACs321 topic
- Chemotherapy-Induced Peripheral Neuropathy291 topic
- Taxanes291 topic
- Genetic Mutations271 topic
- Primary Immunodeficiency271 topic
- Breast Cancer191 topic
- CDK4/6 Inhibitors191 topic
- BCR-ABL171 topic
- Imatinib171 topic
Where does Mark‐David Levin work?
Mark‐David Levin's main affiliation in the publication record is Albert Schweitzer Ziekenhuis, Netherlands.
How many publications and citations does Mark‐David Levin have?
OpenAlex counts 308 works and 6,765 citations for Mark‐David Levin, an h-index of 37, ranking #698,180 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Mark‐David Levin
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Mark‐David Levin. Posts are plain text and can be reported.